Placental Related Disorders of Pregnancy 2.0
1
Department of Microbiology and Immunology, School of Medicine, Massey Cancer Center, Virginia Commonwealth University, Richmond, VA 23298, USA
2
Department of Women and Children’s Health, School of Life Course Sciences, King’s College London, London SE5 9NU, UK
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2023, 24(18), 14286; https://doi.org/10.3390/ijms241814286
Submission received: 6 September 2023
/
Accepted: 8 September 2023
/
Published: 19 September 2023
(This article belongs to the Special Issue Placental Related Disorders of Pregnancy 2.0.)
Following our first Special Issue, we are pleased to present this Special Issue in the International Journal of Molecular Sciences entitled ‘Placental Related Disorders of Pregnancy 2.0′ [1]. The placenta, an extraordinary organ, forms outside the embryo and is connected through a cord of vessels. Its development arises from intricate interactions between fetal and maternal tissues within the pregnant uterus. Unlike stable, mature adult organs, the placenta adapts and performs diverse functions throughout development, making it a dynamically evolving organ. Its primary purpose is to maintain a protected environment for the undisturbed growth and development of the embryo/fetus.
Placental-related disorders are mainly exclusive to humans and affect approximately one-third of pregnancies. These disorders can lead to higher maternal and fetal mortality and morbidity rates, with long-term health consequences for both the mother and child. Changes in human lifestyle, such as delayed childbirth and hypercaloric diets, may have contributed to the increased global incidence of placental-related disorders in recent decades.
This Special Issue is a compilation of 12 research manuscripts and reviews covering all aspects of placentation and its related disorders. The first two systematic reviews investigate pregnancy latency biomarkers after preterm premature rupture of membranes [2] and atypical pre-eclampsia before 20 weeks of gestation [3]. This is followed by detailed reviews of the apelinergic system in pregnancy [4]; serum screen markers for trisomy 21 and the crucial involvement of the placenta [5]; how the placenta can provide a protective role in SARS-CoV-2 transplacental transmission [6]; endoplasmic reticulum aminopeptidase 1 and 2 and their involvement in pregnancy and cancer [7]; and how rodent and rabbit models can be used in pre-eclampsia research [8]. Moreover, this Special Issue also contains original articles with novel data covering hypothyroidism [9] and pre-eclampsia/fetal growth restriction [10,11,12,13].
This second Special Issue focuses on placental research, utilising diverse, well-established, and cutting-edge techniques to present novel and current data. The aim is to deepen and streamline our comprehension of placentation, the mechanisms responsible for adverse outcomes in pregnancy, and the potential long-term risks of complications.
Funding
No external funding was received.
Conflicts of Interest
The authors declare no conflict of interest.
References
- Lee, E.D.; Mistry, H.D. Placental Related Disorders of Pregnancy. Int. J. Mol. Sci. 2022, 23, 3519. [Google Scholar] [CrossRef] [PubMed]
- Feduniw, S.; Pruc, M.; Ciebiera, M.; Zeber-Lubecka, N.; Massalska, D.; Zgliczynska, M.; Pawlowska, A.; Szarpak, L. Biomarkers for Pregnancy Latency Prediction after Preterm Premature Rupture of Membranes-A Systematic Review. Int. J. Mol. Sci. 2023, 24, 8027. [Google Scholar] [CrossRef] [PubMed]
- Modzelewski, J.; Siarkowska, I.; Pajurek-Dudek, J.; Feduniw, S.; Muzyka-Placzynska, K.; Baran, A.; Kajdy, A.; Bednarek-Jedrzejek, M.; Cymbaluk-Ploska, A.; Kwiatkowska, E.; et al. Atypical Preeclampsia before 20 Weeks of Gestation-A Systematic Review. Int. J. Mol. Sci. 2023, 24, 3752. [Google Scholar] [CrossRef] [PubMed]
- Pecheux, O.; Correia-Branco, A.; Cohen, M.; Martinez de Tejada, B. The Apelinergic System in Pregnancy. Int. J. Mol. Sci. 2023, 24, 8014. [Google Scholar] [CrossRef] [PubMed]
- Guibourdenche, J.; Leguy, M.C.; Pidoux, G.; Hebert-Schuster, M.; Laguillier, C.; Anselem, O.; Grange, G.; Bonnet, F.; Tsatsaris, V. Biochemical Screening for Fetal Trisomy 21: Pathophysiology of Maternal Serum Markers and Involvement of the Placenta. Int. J. Mol. Sci. 2023, 24, 7669. [Google Scholar] [CrossRef] [PubMed]
- Wong, Y.P.; Tan, G.C.; Khong, T.Y. SARS-CoV-2 Transplacental Transmission: A Rare Occurrence? An Overview of the Protective Role of the Placenta. Int. J. Mol. Sci. 2023, 24, 4550. [Google Scholar] [CrossRef] [PubMed]
- Hur, B.; Wong, V.; Lee, E.D. A Comparative Review of Pregnancy and Cancer and Their Association with Endoplasmic Reticulum Aminopeptidase 1 and 2. Int. J. Mol. Sci. 2023, 24, 3454. [Google Scholar] [CrossRef]
- Sakowicz, A.; Bralewska, M.; Kamola, P.; Pietrucha, T. Reliability of Rodent and Rabbit Models in Preeclampsia Research. Int. J. Mol. Sci. 2022, 23, 14344. [Google Scholar] [CrossRef] [PubMed]
- Santos, B.R.; Cordeiro, J.; Santos, L.C.; Santana, L.D.S.; Nascimento, A.E.J.; Silva, J.F. Kisspeptin Suppresses Inflammasome-NLRP3 Activation and Pyroptosis Caused by Hypothyroidism at the Maternal-Fetal Interface of Rats. Int. J. Mol. Sci. 2023, 24, 6820. [Google Scholar] [CrossRef] [PubMed]
- Yong, Q.; Dijkstra, K.L.; van der Keur, C.; Bruijn, J.A.; Eikmans, M.; Baelde, H.J. MIF Increases sFLT1 Expression in Early Uncomplicated Pregnancy and Preeclampsia. Int. J. Mol. Sci. 2023, 24, 10050. [Google Scholar] [CrossRef] [PubMed]
- Kurlak, L.O.; Scaife, P.J.; Briggs, L.V.; Broughton Pipkin, F.; Gardner, D.S.; Mistry, H.D. Alterations in Antioxidant Micronutrient Concentrations in Placental Tissue, Maternal Blood and Urine and the Fetal Circulation in Pre-eclampsia. Int. J. Mol. Sci. 2023, 24, 3579. [Google Scholar] [CrossRef] [PubMed]
- Manna, S.; Mc Elwain, C.J.; Maher, G.M.; Giralt Martin, M.; Musumeci, A.; McCarthy, F.P.; McCarthy, C. Heterogenous Differences in Cellular Senescent Phenotypes in Pre-Eclampsia and IUGR following Quantitative Assessment of Multiple Biomarkers of Senescence. Int. J. Mol. Sci. 2023, 24, 3101. [Google Scholar] [CrossRef] [PubMed]
- Feng, Y.; Chen, Q.; Lau, S.Y.; Tsai, B.W.; Groom, K.; Barrett, C.J.; Chamley, L.W. The Blocking of Integrin-Mediated Interactions with Maternal Endothelial Cells Reversed the Endothelial Cell Dysfunction Induced by EVs, Derived from Preeclamptic Placentae. Int. J. Mol. Sci. 2022, 23, 13115. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
MDPI and ACS Style
Lee, E.D.; Mistry, H.D. Placental Related Disorders of Pregnancy 2.0. Int. J. Mol. Sci. 2023, 24, 14286. https://doi.org/10.3390/ijms241814286
AMA Style
Lee ED, Mistry HD. Placental Related Disorders of Pregnancy 2.0. International Journal of Molecular Sciences. 2023; 24(18):14286. https://doi.org/10.3390/ijms241814286
Chicago/Turabian StyleLee, Eun D., and Hiten D. Mistry. 2023. "Placental Related Disorders of Pregnancy 2.0" International Journal of Molecular Sciences 24, no. 18: 14286. https://doi.org/10.3390/ijms241814286
Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.
